ATE174383T1 - Verwendung von tri-n-butylphosphat bei niedrigem ph in lösungen von biologisch aktiven proteinen für eine verbesserte viruzide wirkung - Google Patents

Verwendung von tri-n-butylphosphat bei niedrigem ph in lösungen von biologisch aktiven proteinen für eine verbesserte viruzide wirkung

Info

Publication number
ATE174383T1
ATE174383T1 AT92110522T AT92110522T ATE174383T1 AT E174383 T1 ATE174383 T1 AT E174383T1 AT 92110522 T AT92110522 T AT 92110522T AT 92110522 T AT92110522 T AT 92110522T AT E174383 T1 ATE174383 T1 AT E174383T1
Authority
AT
Austria
Prior art keywords
tri
solutions
low
biologically active
enhanced
Prior art date
Application number
AT92110522T
Other languages
English (en)
Inventor
Milton B Dobkin
George B Dove
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24917171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE174383(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE174383T1 publication Critical patent/ATE174383T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18Liquid substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20211Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20261Methods of inactivation or attenuation
    • C12N2760/20263Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92110522T 1991-07-05 1992-06-23 Verwendung von tri-n-butylphosphat bei niedrigem ph in lösungen von biologisch aktiven proteinen für eine verbesserte viruzide wirkung ATE174383T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72608691A 1991-07-05 1991-07-05

Publications (1)

Publication Number Publication Date
ATE174383T1 true ATE174383T1 (de) 1998-12-15

Family

ID=24917171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92110522T ATE174383T1 (de) 1991-07-05 1992-06-23 Verwendung von tri-n-butylphosphat bei niedrigem ph in lösungen von biologisch aktiven proteinen für eine verbesserte viruzide wirkung

Country Status (8)

Country Link
EP (1) EP0523406B1 (de)
JP (1) JPH05184361A (de)
AT (1) ATE174383T1 (de)
CA (1) CA2072797C (de)
DE (1) DE69227805T2 (de)
DK (1) DK0523406T3 (de)
ES (1) ES2124235T3 (de)
GR (1) GR3029319T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06166634A (ja) * 1992-12-01 1994-06-14 Green Cross Corp:The プラスミノーゲン含有組成物の製造方法
US6034073A (en) * 1995-04-24 2000-03-07 Novavax, Inc. Solvent detergent emulsions having antiviral activity
US6686191B1 (en) * 1995-09-22 2004-02-03 Bayer Healthcare Llc Preparation of virally inactivated intravenously injectable immune serum globulin
US6225289B1 (en) * 1998-12-10 2001-05-01 Genvec, Inc. Methods and compositions for preserving adenoviral vectors
CN1302009C (zh) * 2005-09-05 2007-02-28 武汉海特生物制药股份有限公司 用有机溶剂病毒灭活法制备鼠神经生长因子的工艺
KR100791502B1 (ko) * 2006-09-29 2008-01-03 한스바이오메드 주식회사 바이러스 불활화된 무세포 인체 이식재 생산방법
US8669045B2 (en) 2007-02-13 2014-03-11 Ajinomoto Co., Inc. Method for inactivating viruses with slightly acidic arginine
CN108342368A (zh) * 2018-01-25 2018-07-31 武汉珈创生物技术股份有限公司 一种低pH孵育病毒灭活的验证方法
CN108535491B (zh) * 2018-03-22 2019-11-08 北京九强生物技术股份有限公司 一种肌钙蛋白i的胶乳增强免疫比浊检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3730533A1 (de) * 1987-09-11 1989-03-30 Biotest Pharma Gmbh Verfahren zur sterilisation von plasma oder plasmafraktionen
CA2007545A1 (en) * 1989-01-13 1990-07-13 Yahiro Uemura Production method for protein-containing composition
US5071650A (en) * 1990-06-04 1991-12-10 Miles Inc. Use of intermediate length alcohols as virucidal agents in solutions of biologically active proteins
US5110910A (en) * 1991-03-25 1992-05-05 Miles Inc. Virucidal euglobulin precipitation

Also Published As

Publication number Publication date
DK0523406T3 (da) 1999-08-16
CA2072797C (en) 1998-10-06
JPH05184361A (ja) 1993-07-27
DE69227805T2 (de) 1999-04-29
EP0523406A1 (de) 1993-01-20
GR3029319T3 (en) 1999-05-28
EP0523406B1 (de) 1998-12-09
DE69227805D1 (de) 1999-01-21
ES2124235T3 (es) 1999-02-01
CA2072797A1 (en) 1993-01-06

Similar Documents

Publication Publication Date Title
UA19303A (uk) Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу
ATE133181T1 (de) Dehydrodidemnin b
ES2104605T3 (es) Composiciones estables de acido ascorbico.
DK0511234T3 (da) Stabil injicerbar opløsning af faktor VIII
DK0611522T3 (da) Synergistiske mikrobicide sammensætninger
DE69429336D1 (de) Zusammensetzung von Pflanzenwachstums-Beschleuniger
ATE255903T1 (de) Stabilisierende formulierung für ngf
ATE174383T1 (de) Verwendung von tri-n-butylphosphat bei niedrigem ph in lösungen von biologisch aktiven proteinen für eine verbesserte viruzide wirkung
EP0591378A4 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie.
DE68910382D1 (de) Oxabicycloalkan-ether als Herbizide.
ATE186567T1 (de) Verwendung von azolen als virustötende substanzen in lösungen von biologisch aktiven proteinen
ATE41927T1 (de) Phenylalkylamine - bioregulatoren.
BG44533A3 (bg) Хербициден състав и метод за контрол на нежелана растителност
ATE66921T1 (de) Verwendung von triazolylderivate zur bekaempfung von pilzen.
ES2125849T3 (es) 1-dimetilcarbamoil-3-sustituido-5-sustituido-1h-1,2,4-triazoles.
BG45041A3 (bg) Хербициден състав
BG42351A3 (bg) Средство за регулиране растежа на растения
DE3870019D1 (de) Herbizides verfahren unter benutzung von diflufenican.
FR2574798B1 (fr) Nouvelle adenosine substituee en n6 et medicament la contenant comme principe actif
ATE86292T1 (de) Verwendung von monocarbonsaeurepolyoxyalkylester - sulfonaten als schaumarme textilbehandlungsmittel.
DE68906794D1 (de) Zubereitungen zur behandlung von leishmaniasis.